ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED OrbusNeich Medical Group Holdings Limited Share Price
Equities
6929
KYG6773B1005
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.83 HKD | +4.08% |
|
+6.09% | -45.67% |
| 03-07 | OrbusNeich Medical Group’s Profit Up 144% in 2023 | MT |
| 03-07 | OrbusNeich Medical Group Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 28 June 2024 | CI |
| Sales 2024 * | 1.28B 176M 1.38B 14.11B | Sales 2025 * | 1.48B 205M 1.6B 16.39B | Capitalization | 2.94B 405M 3.17B 32.44B |
|---|---|---|---|---|---|
| Net income 2024 * | 336M 46.37M 363M 3.71B | Net income 2025 * | 386M 53.27M 417M 4.27B | EV / Sales 2024 * | 0.8 x |
| Net cash position 2024 * | 1.91B 264M 2.07B 21.15B | Net cash position 2025 * | 2.33B 322M 2.52B 25.77B | EV / Sales 2025 * | 0.41 x |
| P/E ratio 2024 * |
9.01
x | P/E ratio 2025 * |
7.54
x | Employees | 1,249 |
| Yield 2024 * |
2.54% | Yield 2025 * |
2.85% | Free-Float | 36.97% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +4.08% | ||
| 1 week | +6.09% | ||
| Current month | +18.94% | ||
| 1 month | +26.40% | ||
| 3 months | -30.49% | ||
| 6 months | -56.82% | ||
| Current year | -45.67% |
1 week
3.43
3.88
1 month
3.073.88
Current year
3.017.06
1 year
3.0114.82
3 years
3.0116.86
5 years
3.0116.86
10 years
3.0116.86
| Managers | Title | Age | Since |
|---|---|---|---|
David Chien
CEO | Chief Executive Officer | 59 | 21/07/21 |
Wing Shing Chen
DFI | Director of Finance/CFO | 43 | 21/07/21 |
Robert Cottone
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Chien
CEO | Chief Executive Officer | 59 | 21/07/21 |
Yip Keung Chan
BRD | Director/Board Member | 40 | 28/09/21 |
Ka Keung Lau
BRD | Director/Board Member | 48 | 28/09/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 3.83 | +4.08% | 510,500 |
| 25/04/24 | 3.68 | +0.55% | 82,000 |
| 24/04/24 | 3.66 | +6.40% | 230,500 |
| 23/04/24 | 3.44 | -3.64% | 90,000 |
| 22/04/24 | 3.57 | -1.11% | 100,500 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
OrbusNeich Medical Group Holdings Ltd is an investment holding company principally engaged in the development, production and sales of medical equipment and machineries. The Company is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The Company's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The Company mainly conducts its businesses in domestic and overseas markets.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.545
CNY
Average target price
6.393
CNY
Spread / Average Target
+80.33%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -45.67% | 405M | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- 6929 Stock
